Skip to main content
Top
Published in: BMC Infectious Diseases 1/2011

Open Access 01-12-2011 | Research article

Delta neutrophil index as an early marker of disease severity in critically ill patients with sepsis

Authors: Byung Hoon Park, Young Ae Kang, Moo Suk Park, Won Jai Jung, Su Hwan Lee, Sang Kook Lee, Song Yee Kim, Se Kyu Kim, Joon Chang, Ji Ye Jung, Young Sam Kim

Published in: BMC Infectious Diseases | Issue 1/2011

Login to get access

Abstract

Background

The immature granulocyte count has been reported to be a marker of infection and sepsis. The difference in leukocyte subfractions (delta neutrophil index, DNI) in ADVIA 2120 reflects the fraction of circulating immature granulocytes in the blood. This study evaluated the clinical utility of DNI as a severity and prediction marker in critically ill patients with sepsis.

Methods

One hundred and three patients admitted to the medical intensive care unit with sepsis were studied. DNI (the difference in leukocyte subfractions identified by myeloperoxidase and nuclear lobularity channels) was determined using a specific blood cell analyzer.

Results

Forty four patients (42.7%) were diagnosed with severe sepsis/septic shock. Overt disseminated intravascular coagulation (DIC) occurred in 40 (38.8%). DNI was significantly higher in patients with severe sepsis/septic shock and overt DIC than in patients without (p < 0.05). DNI correlated with DIC score (r = 0.54, p < 0.001). We observed a monotonic increase in the proportion of overt DIC and severe sepsis/septic shock associated with increasing quartiles of DNI (p < 0.001). A DNI value > 6.5% was a better indicator of severe sepsis/septic shock than C-reactive protein, lactate, white blood cell count, and absolute neutrophil count (sensitivity, 81.3%; specificity, 91.0%; positive predictive value, 88.6%; and negative predictive value, 84.7%). In 36 (82%) of the 44 patients with severe sepsis/septic shock, DNI values were already elevated up to 12 hours before the onset of organ/circulatory failure.

Conclusions

DNI may be used as a marker of disease severity in critically ill patients with sepsis. High levels of DNI may help to identify patients with an impending risk of developing severe sepsis/septic shock.
Appendix
Available only for authorised users
Literature
1.
go back to reference Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001, 345 (19): 1368-1377. 10.1056/NEJMoa010307.CrossRefPubMed Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001, 345 (19): 1368-1377. 10.1056/NEJMoa010307.CrossRefPubMed
2.
go back to reference Annane D, Aegerter P, Jars-Guincestre MC, Guidet B: Current epidemiology of septic shock: the CUB-Rea Network. Am J Respir Crit Care Med. 2003, 168 (2): 165-172. 10.1164/rccm.2201087.CrossRefPubMed Annane D, Aegerter P, Jars-Guincestre MC, Guidet B: Current epidemiology of septic shock: the CUB-Rea Network. Am J Respir Crit Care Med. 2003, 168 (2): 165-172. 10.1164/rccm.2201087.CrossRefPubMed
3.
go back to reference Annane D, Bellissant E, Cavaillon JM: Septic shock. Lancet. 2005, 365 (9453): 63-78. 10.1016/S0140-6736(04)17667-8.CrossRefPubMed Annane D, Bellissant E, Cavaillon JM: Septic shock. Lancet. 2005, 365 (9453): 63-78. 10.1016/S0140-6736(04)17667-8.CrossRefPubMed
4.
go back to reference Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, et al: Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006, 34 (6): 1589-1596. 10.1097/01.CCM.0000217961.75225.E9.CrossRefPubMed Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, et al: Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006, 34 (6): 1589-1596. 10.1097/01.CCM.0000217961.75225.E9.CrossRefPubMed
5.
go back to reference Marshall JC: Sepsis: rethinking the approach to clinical research. J Leukoc Biol. 2008, 83 (3): 471-482.CrossRefPubMed Marshall JC: Sepsis: rethinking the approach to clinical research. J Leukoc Biol. 2008, 83 (3): 471-482.CrossRefPubMed
6.
go back to reference Kofoed K, Andersen O, Kronborg G, Tvede M, Petersen J, Eugen-Olsen J, Larsen K: Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study. Crit Care. 2007, 11 (2): R38.-CrossRefPubMedPubMedCentral Kofoed K, Andersen O, Kronborg G, Tvede M, Petersen J, Eugen-Olsen J, Larsen K: Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study. Crit Care. 2007, 11 (2): R38.-CrossRefPubMedPubMedCentral
7.
go back to reference Shapiro NI, Trzeciak S, Hollander JE, Birkhahn R, Otero R, Osborn TM, Moretti E, Nguyen HB, Gunnerson KJ, Milzman D, et al: A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis. Crit Care Med. 2009, 37 (1): 96-104. 10.1097/CCM.0b013e318192fd9d.CrossRefPubMed Shapiro NI, Trzeciak S, Hollander JE, Birkhahn R, Otero R, Osborn TM, Moretti E, Nguyen HB, Gunnerson KJ, Milzman D, et al: A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis. Crit Care Med. 2009, 37 (1): 96-104. 10.1097/CCM.0b013e318192fd9d.CrossRefPubMed
8.
go back to reference Gonsalves MD, Sakr Y: Early identification of sepsis. Curr Infect Dis Rep. 12 (5): 329-335. Gonsalves MD, Sakr Y: Early identification of sepsis. Curr Infect Dis Rep. 12 (5): 329-335.
9.
go back to reference Cornbleet PJ: Clinical utility of the band count. Clin Lab Med. 2002, 22 (1): 101-136. 10.1016/S0272-2712(03)00069-6.CrossRefPubMed Cornbleet PJ: Clinical utility of the band count. Clin Lab Med. 2002, 22 (1): 101-136. 10.1016/S0272-2712(03)00069-6.CrossRefPubMed
10.
go back to reference Ardron MJ, Westengard JC, Dutcher TF: Band neutrophil counts are unnecessary for the diagnosis of infection in patients with normal total leukocyte counts. Am J Clin Pathol. 1994, 102 (5): 646-649.CrossRefPubMed Ardron MJ, Westengard JC, Dutcher TF: Band neutrophil counts are unnecessary for the diagnosis of infection in patients with normal total leukocyte counts. Am J Clin Pathol. 1994, 102 (5): 646-649.CrossRefPubMed
11.
go back to reference Seebach JD, Morant R, Ruegg R, Seifert B, Fehr J: The diagnostic value of the neutrophil left shift in predicting inflammatory and infectious disease. Am J Clin Pathol. 1997, 107 (5): 582-591.CrossRefPubMed Seebach JD, Morant R, Ruegg R, Seifert B, Fehr J: The diagnostic value of the neutrophil left shift in predicting inflammatory and infectious disease. Am J Clin Pathol. 1997, 107 (5): 582-591.CrossRefPubMed
12.
go back to reference Selig C, Nothdurft W: Cytokines and progenitor cells of granulocytopoiesis in peripheral blood of patients with bacterial infections. Infect Immun. 1995, 63 (1): 104-109.PubMedPubMedCentral Selig C, Nothdurft W: Cytokines and progenitor cells of granulocytopoiesis in peripheral blood of patients with bacterial infections. Infect Immun. 1995, 63 (1): 104-109.PubMedPubMedCentral
13.
go back to reference Ansari-Lari MA, Kickler TS, Borowitz MJ: Immature granulocyte measurement using the Sysmex XE-2100. Relationship to infection and sepsis. Am J Clin Pathol. 2003, 120 (5): 795-799. 10.1309/LT30BV9UJJV9CFHQ.CrossRefPubMed Ansari-Lari MA, Kickler TS, Borowitz MJ: Immature granulocyte measurement using the Sysmex XE-2100. Relationship to infection and sepsis. Am J Clin Pathol. 2003, 120 (5): 795-799. 10.1309/LT30BV9UJJV9CFHQ.CrossRefPubMed
14.
go back to reference Nigro KG, O'Riordan M, Molloy EJ, Walsh MC, Sandhaus LM: Performance of an automated immature granulocyte count as a predictor of neonatal sepsis. Am J Clin Pathol. 2005, 123 (4): 618-624. 10.1309/73H7K7UBW816PBJJ.CrossRefPubMed Nigro KG, O'Riordan M, Molloy EJ, Walsh MC, Sandhaus LM: Performance of an automated immature granulocyte count as a predictor of neonatal sepsis. Am J Clin Pathol. 2005, 123 (4): 618-624. 10.1309/73H7K7UBW816PBJJ.CrossRefPubMed
15.
go back to reference Kratz A, Maloum K, O'Malley C, Zini G, Rocco V, Zelmanovic D, Kling G: Enumeration of nucleated red blood cells with the ADVIA 2120 Hematology System: an International Multicenter Clinical Trial. Lab Hematol. 2006, 12 (2): 63-70. 10.1532/LH96.06010.CrossRefPubMed Kratz A, Maloum K, O'Malley C, Zini G, Rocco V, Zelmanovic D, Kling G: Enumeration of nucleated red blood cells with the ADVIA 2120 Hematology System: an International Multicenter Clinical Trial. Lab Hematol. 2006, 12 (2): 63-70. 10.1532/LH96.06010.CrossRefPubMed
16.
go back to reference Harris N, Jou JM, Devoto G, Lotz J, Pappas J, Wranovics D, Wilkinson M, Fletcher SR, Kratz A: Performance evaluation of the ADVIA 2120 hematology analyzer: an international multicenter clinical trial. Lab Hematol. 2005, 11 (1): 62-70. 10.1532/LH96.04064.CrossRefPubMed Harris N, Jou JM, Devoto G, Lotz J, Pappas J, Wranovics D, Wilkinson M, Fletcher SR, Kratz A: Performance evaluation of the ADVIA 2120 hematology analyzer: an international multicenter clinical trial. Lab Hematol. 2005, 11 (1): 62-70. 10.1532/LH96.04064.CrossRefPubMed
17.
go back to reference Harris N, Kunicka J, Kratz A: The ADVIA 2120 hematology system: flow cytometry-based analysis of blood and body fluids in the routine hematology laboratory. Lab Hematol. 2005, 11 (1): 47-61. 10.1532/LH96.04075.CrossRefPubMed Harris N, Kunicka J, Kratz A: The ADVIA 2120 hematology system: flow cytometry-based analysis of blood and body fluids in the routine hematology laboratory. Lab Hematol. 2005, 11 (1): 47-61. 10.1532/LH96.04075.CrossRefPubMed
18.
go back to reference Nahm CH, Choi JW, Lee J: Delta neutrophil index in automated immature granulocyte counts for assessing disease severity of patients with sepsis. Ann Clin Lab Sci. 2008, 38 (3): 241-246.PubMed Nahm CH, Choi JW, Lee J: Delta neutrophil index in automated immature granulocyte counts for assessing disease severity of patients with sepsis. Ann Clin Lab Sci. 2008, 38 (3): 241-246.PubMed
19.
go back to reference Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003, 31 (4): 1250-1256. 10.1097/01.CCM.0000050454.01978.3B.CrossRefPubMed Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003, 31 (4): 1250-1256. 10.1097/01.CCM.0000050454.01978.3B.CrossRefPubMed
20.
go back to reference Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, et al: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008, 36 (1): 296-327. 10.1097/01.CCM.0000298158.12101.41.CrossRefPubMed Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, et al: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008, 36 (1): 296-327. 10.1097/01.CCM.0000298158.12101.41.CrossRefPubMed
21.
go back to reference Metnitz PG, Moreno RP, Almeida E, Jordan B, Bauer P, Campos RA, Iapichino G, Edbrooke D, Capuzzo M, Le Gall JR: SAPS 3--From evaluation of the patient to evaluation of the intensive care unit. Part 1: Objectives, methods and cohort description. Intensive Care Med. 2005, 31 (10): 1336-1344. 10.1007/s00134-005-2762-6.CrossRefPubMedPubMedCentral Metnitz PG, Moreno RP, Almeida E, Jordan B, Bauer P, Campos RA, Iapichino G, Edbrooke D, Capuzzo M, Le Gall JR: SAPS 3--From evaluation of the patient to evaluation of the intensive care unit. Part 1: Objectives, methods and cohort description. Intensive Care Med. 2005, 31 (10): 1336-1344. 10.1007/s00134-005-2762-6.CrossRefPubMedPubMedCentral
22.
go back to reference Moreno RP, Metnitz PG, Almeida E, Jordan B, Bauer P, Campos RA, Iapichino G, Edbrooke D, Capuzzo M, Le Gall JR: SAPS 3--From evaluation of the patient to evaluation of the intensive care unit. Part 2: Development of a prognostic model for hospital mortality at ICU admission. Intensive Care Med. 2005, 31 (10): 1345-1355. 10.1007/s00134-005-2763-5.CrossRefPubMedPubMedCentral Moreno RP, Metnitz PG, Almeida E, Jordan B, Bauer P, Campos RA, Iapichino G, Edbrooke D, Capuzzo M, Le Gall JR: SAPS 3--From evaluation of the patient to evaluation of the intensive care unit. Part 2: Development of a prognostic model for hospital mortality at ICU admission. Intensive Care Med. 2005, 31 (10): 1345-1355. 10.1007/s00134-005-2763-5.CrossRefPubMedPubMedCentral
23.
go back to reference Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996, 22 (7): 707-710. 10.1007/BF01709751.CrossRefPubMed Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996, 22 (7): 707-710. 10.1007/BF01709751.CrossRefPubMed
24.
go back to reference Taylor FB, Toh CH, Hoots WK, Wada H, Levi M: Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001, 86 (5): 1327-1330.PubMed Taylor FB, Toh CH, Hoots WK, Wada H, Levi M: Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001, 86 (5): 1327-1330.PubMed
25.
go back to reference Levi M, de Jonge E, van der Poll T: Sepsis and disseminated intravascular coagulation. J Thromb Thrombolysis. 2003, 16 (1-2): 43-47.CrossRefPubMed Levi M, de Jonge E, van der Poll T: Sepsis and disseminated intravascular coagulation. J Thromb Thrombolysis. 2003, 16 (1-2): 43-47.CrossRefPubMed
26.
go back to reference Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C, Schortgen F, Lasocki S, Veber B, Dehoux M, et al: Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet. 375 (9713): 463-474. Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C, Schortgen F, Lasocki S, Veber B, Dehoux M, et al: Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet. 375 (9713): 463-474.
27.
go back to reference Dahaba AA, Hagara B, Fall A, Rehak PH, List WF, Metzler H: Procalcitonin for early prediction of survival outcome in postoperative critically ill patients with severe sepsis. Br J Anaesth. 2006, 97 (4): 503-508. 10.1093/bja/ael181.CrossRefPubMed Dahaba AA, Hagara B, Fall A, Rehak PH, List WF, Metzler H: Procalcitonin for early prediction of survival outcome in postoperative critically ill patients with severe sepsis. Br J Anaesth. 2006, 97 (4): 503-508. 10.1093/bja/ael181.CrossRefPubMed
28.
go back to reference Tang BM, Eslick GD, Craig JC, McLean AS: Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis. 2007, 7 (3): 210-217. 10.1016/S1473-3099(07)70052-X.CrossRefPubMed Tang BM, Eslick GD, Craig JC, McLean AS: Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis. 2007, 7 (3): 210-217. 10.1016/S1473-3099(07)70052-X.CrossRefPubMed
Metadata
Title
Delta neutrophil index as an early marker of disease severity in critically ill patients with sepsis
Authors
Byung Hoon Park
Young Ae Kang
Moo Suk Park
Won Jai Jung
Su Hwan Lee
Sang Kook Lee
Song Yee Kim
Se Kyu Kim
Joon Chang
Ji Ye Jung
Young Sam Kim
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2011
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-11-299

Other articles of this Issue 1/2011

BMC Infectious Diseases 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.